Summary & Overview
HCPCS Q9963: High Osmolar Iodinated Contrast, 350-399 mg/ml
HCPCS Level II code Q9963 identifies a high osmolar iodinated contrast agent with an iodine concentration of 350–399 mg/ml billed per milliliter. This code matters nationally because accurate coding of contrast media affects imaging service costs, claim adjudication, and downstream payment policy for CT, angiography, and interventional radiology procedures. Use of Q9963 distinguishes high osmolar formulations from other contrast categories for inventory tracking and payer pricing.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication reviews payer coverage patterns, common modifier usage, and clinical contexts in which high osmolar contrast is administered.
Readers will learn: payer coverage considerations and where Q9963 typically appears on claims; clinical settings and imaging services that commonly use high osmolar iodinated contrast; billing nuances such as per-milliliter supply reporting; and benchmarks and policy updates relevant to contrast agent coding. Data not available in the input is noted where applicable. The summary equips coding managers, billing professionals, and radiology administrators with a concise reference to support accurate claim submission and reconciliation for high osmolar iodinated contrast material.
Billing Code Overview
HCPCS Level II code Q9963 describes high osmolar contrast material, 350-399 mg/ml iodine concentration, per ml. This supply-level code is used to bill for intravenous radiology contrast agents measured and charged by volume.
Service type: Radiology contrast agent administration (intravenous contrast material)
Typical site of service: Imaging suites, hospital radiology departments, outpatient imaging centers, and interventional radiology settings
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult undergoing a contrast-enhanced diagnostic imaging study such as a computed tomography (CT) scan of the chest, abdomen, pelvis, or angiographic procedure where an iodinated high-osmolar contrast agent with concentration between 350–399 mg/ml iodine is required. The patient often presents with acute abdominal pain, suspected pulmonary embolism, trauma, or evaluation of vascular anatomy. Prior to the study, clinical staff obtain informed consent, review allergy and renal function (serum creatinine/eGFR), and establish intravenous access suitable for power injection. During the study, a radiologist or interventionalist directs contrast volume and injection rate; nursing monitors for immediate reactions. Post-procedure, the patient is observed for adverse events (e.g., contrast reaction, extravasation) and instructed on hydration and follow-up as indicated. Typical sites of service include hospital outpatient imaging centers, emergency departments, inpatient radiology suites, and ambulatory surgical centers when used for angiography or interventional procedures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Unspecified | Rarely used; only when no other modifier applies and payer permits |
11 |